Treść książki
Przejdź do opcji czytnikaPrzejdź do nawigacjiPrzejdź do informacjiPrzejdź do stopki
Piśmiennictwo
35
VbyfactorXaandthrombin.Biochemistry1990,29,1118-1128.490ColmanR.W.:Contactactivation
(kallikrein-kinin)pathway:Multiplephysiologicandpathophysiologicactivities.W:Hemostasisand
Trombosis.BasicPrinciplesandClinicalPractice(red.R.W.Colman,V.J.Marder,A.W.Clowes,J.N.George,
S.Z.Goldhaber).LippincottWilliamsandWilkins,Philadelphia2006,107-130.500MannK.G.:Trombin
formation.Chest2003,124,4S-10S.510ButenasS.,OrfeoT.,MannK.:Tissuefactorincoagulation.Which?
Where?When?Arterioscler.Tromb.Vasc.Biol.2009,29,1989-1996.520OrfeoT.,ButenasS.,Brummel-
-ZiedinsK.E.,MannK.G.:Thetissuefactorrequirementinbloodcoagulation.J.Biol.Chem.2005,280,
42887-42896.530StefelJ.,LfischerT.,TannerF.:Tissuefactorincardiovasculardiseases:Molecular
mechanismsandclinicalimplications.Circulation2006,113(5),722-731.540BajajS.P.,TompsonA.R.:
MolecularandstructuralbiologyoffactorIX.W:HemostasisandTrombosis.BasicPrinciplesandClini-
calPractice(red.R.W.Colman,V.J.Marder,A.W.Clowes,J.N.George,S.Z.Goldhaber).LippincottWilliams
andWilkins,Philadelphia2006,131-150.550DavieE.W.,KulmanJ.D.:Anoverviewofthestructureand
functionofthrombin.Semin.Tromb.Haemost.2006,32(supl.1),3-15.560JennyN.S.,LundbladR.L.,
MannK.G.:Trombin.W:HemostasisandTrombosis.BasicPrinciplesandClinicalPractice(red.
R.W.Colman,V.J.Marder,A.W.Clowes,J.N.George,S.Z.Goldhaber).LippincottWilliamsandWilkins,
Philadelphia2006,193-214.570MannK.G.:Trombingenerationinhemorrhagecontrolandvascularoc-
clusion.Circulation2011,124,225-235.580MannK.G.,ButenasS.,BrummelK.:Tedynamicsofthrombin
formation.Arterioscl.Tromb.Vasc.Biol.2003,23,17-25.590DahlbackB.:Bloodcoagulationandits
regulationbyanticoagulantpathways:Geneticpathogenesisofbleedingandthromboticdiseases.J.Intern.
Med.2005,257(3),209-223.600DahlbackB.,VilloutreixB.O.:TeanticoagulantproteinCpathway.FEBS
Lett.2005,579(15),3310-3316.610LwaleedB.A.,BassP.S.:Tissuefactorpathwayinhibitor:Structure,biol-
ogyandinvolvementindisease.J.Pathol.2006,208(3),327-339.620RigbyA.C.,GrantM.A.:ProteinS:
Aconduitbetweenanticoagulationandinflammation.Crit.CareMed.2004,32(supl.5),S336-S341.
630BockS.C.:AntithrombinIIIandheparincofactorII.W:HemostasisandTrombosis.BasicPrinciples
andClinicalPractice(red.R.W.Colman,V.J.Marder,A.W.Clowes,J.N.George,S.Z.Goldhaber).Lippin-
cottWilliamsandWilkins,Philadelphia2006,235-248.640HartJ.P.,PizzoS.V
.:O-macroglobulinsand
kunins.W:HemostasisandTrombosis.BasicPrinciplesandClinicalPractice(red.R.W.Colman,
V.J.Marder,A.W.Clowes,J.N.George,S.Z.Goldhaber).LippincottWilliamsandWilkins,Philadelphia
2006,395-408.650BrozeG.Jr,MiletichJ.:HumanproteinZ.J.Clin.Invest.1984,73,933-938.660Mann
K.G.,KalafatisM.:FactorV:AcombinationofDr.JekyllandMr.Hyde.Blood2003,101,20-30.670Kane
W.H.,DavieE.W.:BloodcoagulationfactorVandVIII:Structuralandfunctionalsimilaritiesandtheir
relationshiptohemorrhagicandthromboticdisorders.Blood1988,71,539-555.680KaneW.H.:FactorV.
W:HemostasisandTrombosis.BasicPrinciplesandClinicalPractice(red.R.W.Colman,V.J.Marder,
A.W.Clowes,J.N.George,S.Z.Goldhaber).LippincottWilliamsandWilkins,Philadelphia2006,177-192.
690KaufmanR.J.,AntonarakisS.E.,FayP.J.:FactorVIIIandhemophiliaA.W:HemostasisandTrombo-
sis.BasicPrinciplesandClinicalPractice(red.R.W.Colman,V.J.Marder,A.W.Clowes,J.N.George,
S.Z.Goldhaber).LippincottWilliamsandWilkins,Philadelphia2006,151-175.700MuszbekL.,Bagoly
Z.,BereczkyZ.,KatonaE.:TeinvolvementofbloodcoagulationfactorXIIIinfbrinolysisandthrombosis.
Cardiovasc.Hematol.AgentsMed.Chem.2008,6,190-205.710ButenasS.,DeeJ.,MannK.:Thefunction
offactorXIintissuefactor-initiatedthrombingeneration.J.Tromb.Haemost.2003,1,2103-2111.
720BoumaB.N.,MosnierL.O.:Trombinactivatablefbrinolysisinhibitor(TAFI)-howdoesthrombin
regulatefbrinolysis?Ann.Med.2006,38,378-388.730MarderV.J.,FrancisC.W.:Physiologicregulation
offibrinolysis.W:HemostasisandTrombosis.BasicPrinciplesandClinicalPractice(red.R.W.Colman,
V.J.Marder,A.W.Clowes,J.N.George,S.Z.Goldhaber).LippincottWilliamsandWilkins,Philadelphia
2006,419-436.740ZorioE.iwsp.:Fibrinolysis:Tekeytonewpathogeneticmechanisms.Curr.Med.Chem.
2008,15,923-929.750Cesarman-MausG.,HajjarK.A.:Molecularmechanismsoffbrinolysis.Br.J.Hae-
matol.2005,129,307-321.760BlombäckB.:Fibrinogenandfbrin-proteinswithcomplexrolesinhemo-
stasisandthrombosis.Tromb.Res.1996,83,1-75.770MosessonM.W.:Fibrinogenandfbrinstructure
andfunctions.J.Tromb.Haemost.2005,3,1894-1904.780FrankP.S.,DouglasJ.T.,LocherM.,LlinasM.,
SchallerJ.:Structural/functionalcharacterizationofthealpha2-plasmininhibitorC-terminalpeptide.
Biochemistry2003,42,1078-1085.790ChristiansenV.J.,JacksonK.W.,LeeK.N.,McKeeP.A.:Teelectof
asinglenucleotidepolymorphismonhumanalpha2-antiplasminactivity.Blood2007,109,5286-5292.
800NarH.,BauerM.,StassenJ.M.,LangD.,GilsA.,DeclerckP.J.:Plasminogenactivatorinhibitor1.Struc-
tureofthenativeserpin,comparisontoitsotherconformersandimplicationsforserpininactivation.J.Mol.
Biol.2000,297,683-695.810FoleyJ.H.,KimP.,NesheimM.E.:Trombin-activablefbrinolysisinhibitor
zymogendoesnotplayasignifcantroleintheattenuationoffbrinolysis.J.Biol.Chem.2008,283,8863-8867.
